This study confirms the upregulation of UCHL1, SNRNP200, and PAK4 as significant factors in the progression of high-grade CCRCC, linking their enhanced expression to poor clinical outcomes. This evidence concerns the gene UCHL1 and nonpapillary renal cell carcinoma.